- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01682096
Pilot Safety Study of Coronary CTA for the Diagnosis of Acute Coronary Syndrome in the Emergency Room
Usefulness of Coronary CTA for the Diagnosis of Acute Coronary Syndrome in the Emergency Room.
The Diagnosis of acute coronary syndrome in patients presenting with acute chest pain is problematic when both, electrocardiogram and serum troponins are normal. Multidetector row computed tomography angiography (CTA) allows direct and rapid non-invasive visualization of coronary artery disease.
The investigator's aim is to assess the diagnostic accuracy and safety of a novel diagnostic strategy based on MDCT as compared to a strategy using stress echocardiography in the workup of patient with chest pain, normal electrocardiogram, normal troponins and suspected coronary artery disease. Additionally, the cost associated with both strategies will be compared.
Methods. A total of 150 patients with acute chest pain coming to the emergency room with intermediate probability of significant coronary artery disease, normal ECG and troponins will be prospectively randomized to MDCT or stress echocardiography with exercise. Patients showing coronary stenosis >50% at MDCT or abnormal stress echocardiography or inconclusive results will be admitted for further study. The primary endpoint of the study is the detection of an acute coronary syndrome, defined as typical or atypical angina with documented significant coronary artery disease (>50% stenosis) on invasive coronariography, a positive stress test or the occurrence of cardiac death, myocardial infarction or need for revascularization during 6 month follow-up. All MDCT angiograms and echocardiograms will be evaluated by an experienced radiologist and cardiologist.
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Design and Aim: This is a prospective pilot study to evaluate the role of multidetector row computed tomography angiography (CTA) to rule out Acute Coronary Syndrome among patients presenting to the ER with chest pain complaints, non-diagnostic ECG and normal troponins and intermediate pre-test probability for significant CAD.
Methods: Following the initial clinical evaluation and the results of initial ECG, blood test and X-ray, patients meeting the inclusion criteria will be randomized to undergo either a CTA scan or a Exercise Stress Echocardiogram to rule out significant coronary artery disease.
CTA will be carried out in a 64 or 128 slice-CT Scanner (SIEMENS,Somaton Sensation 64 or 128-Flash Definition)following iv administration of iodinated contrast (bolus: 5cc x acquisition time (seg)+ 10 cc). Images will be interpreted by two experienced physicians (radiologist and cardiologist)
Stress Echocardiography will be performed and interpreted by an experienced Echocardiographer (cardiologist).
Clinical decision making: Patients with a positive or inconclusive test in each arm will be admitted to the hospital for treatment or further additional testing, while patients with negative results will be discharged from the ER.
Safety issues: A phone call and chart review will be performed one month and 6 months follow-up to register the occurrence of any major adverse cardiac events, as well as new consultation for chest pain.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Catalonia
-
Barcelona, Catalonia, Spanien, 08036
- Hospital Clinic Barcelona
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patient is in Sinus Rhythm
- Typical or atypical chest pain lasting more than 5 min in the last 24 hs.
- Estimated pre-test probability of significant coronary artery disease more than 15%.
- Absence of ECG changes suggestive of myocardial ischemia (ST-segment deviation >1 mm or T Wave inversion > 4 mm in at least two contiguous leads).
- Negative initial troponins I at admission (<0.05 ng/ml)
Exclusion Criteria:
- Known allergy to iodinated contrast.
- Known renal insufficiency or Creatinine >1.5 mg/dl at admission.
- History of known coronary artery disease or prior myocardial revascularization
- Any of the following:hemodynamic instability, persistent chest pain despite treatment, Systolic blood pressure <100 mm Hg.
- Cardiac arrhythmia with rapid or irregular ventricular response.
- Inability to perform an exercise test.
- Patient is incapable of providing informed consent.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Computed coronary angiography (CTA)
Patients will undergo a MDCT as the initial diagnostic test to rule out Acute Coronary Syndrome
|
Patients will be pre-medicated with atenolol 50 mg 1h prior to the scan.
Andre navne:
|
|
Aktiv komparator: Exercise stress echocardiography
Patients will undergo exercise stress echocardiography as the initial diagnostic test to rule out acute coronary syndrome.
|
Limited by symptoms
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Diagnosis of Acute Coronary Syndrome during admission or occurrence of Major Acute Cardiac Events after discharge
Tidsramme: 6 months
|
Major adverse cardiac events include: All cause mortality, acute myocardial infarction, need for coronary revascularization
|
6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Major adverse cardiac events on follow-up
Tidsramme: 6 months
|
Safety endpoint: occurrence of MACE among discharged patients in whom acute coronary syndrome has been ruled out according to the test results
|
6 months
|
|
Costs during admission (Euros)
Tidsramme: 6 months
|
The total costs derivated from the admission between the two arms of the study will be compared.
Results will be reported in Euros, and will include the costs of the CTA or Stress echocardiography as well as additional tests performed during admission.
|
6 months
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Time to clinical decision
Tidsramme: first 24 hs.
|
Time from patient admission to the clinical decision (admission for further testing or discharge from the ER) between the two arms.
|
first 24 hs.
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: José T Ortiz-Perez, MD, PhD, Hospital Clinic of Barcelona
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PI09/90513
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Myokardieinfarkt
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RekrutteringMyocardial skade efter ikke -hjertekirurgiForenede Stater
-
Sichuan Provincial People's HospitalTilmelding efter invitationRest Gated Myocardial Perfusion Imaging ved hjertesvigtKina
-
Azienda Ospedaliero Universitaria Maggiore della...Università degli Studi del Piemonte Orientale "Amedeo Avogadro"Rekruttering
-
Fondazione Policlinico Universitario Agostino Gemelli...Afsluttet
-
Peking University Third HospitalAfsluttet
-
Stanford UniversityAfsluttetMyocardial brodannelseForenede Stater
-
Izmir Bakircay UniversityAfsluttetMyokardiebro af kranspulsårenKalkun
-
Centre Hospitalier Sud FrancilienAfsluttetAkut anterior koroidal infarkt (ACI) | Paramedian Pontine Infarction (IPP)Frankrig
-
ITAB - Institute for Advanced Biomedical TechnologiesAzienda Ospedaliero, Universitaria Ospedali RiunitiAfsluttetMyokardiebro af kranspulsårenItalien
-
Southeast University, ChinaRekrutteringMyocardial iskæmi-reperfusionsskadeKina
Kliniske forsøg med computed coronary angiography
-
Jordan Collaborating Cardiology GroupAfsluttet
-
Hemolens Diagnostics Sp. z o.o.KCRIAfsluttet
-
Hemolens Diagnostics Sp. z o.o.GENELYTICA Sp. z o.o.AfsluttetKoronararteriesygdom | Stabil iskæmisk hjertesygdomPolen
-
Emory UniversityNational Heart, Lung, and Blood Institute (NHLBI); Samsung Medical Center; Chonnam National University Hospital og andre samarbejdspartnereAfsluttetKoronararteriesygdomKorea, Republikken, Forenede Stater
-
Hospices Civils de LyonAfsluttetCochleære implantaterFrankrig
-
Pusan National University HospitalUkendtGrøn stær, åben vinkel | AngiografiKorea, Republikken
-
Central Hospital, Nancy, FranceAfsluttet
-
Elixir Medical CorporationAfsluttet
-
University Hospital, Strasbourg, FranceAfsluttet
-
University of BernITI FoundationAfsluttet